BeStock  

BioLife Solutions BLFS

US equityMarket cap rank #2817Medical Instruments & Supplies
$38.61 +$1.31 (+3.51%)
Market closed · Oct 6, 4:00 am ET · Last extended-hours $38.61 0.00%
Open$37.16
Prev close$37.30
Day range$36.95 – $38.83
Volume4.45M
Market cap$1.89B
P/E (TTM)32.7
Dividend yield–

Balance sheet

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Gains/Losses Not Affecting Retained Earnings -$211,000.00 -$120,000.00 $132,000.00 $130,000.00 $71,000.00
-Gross PPE $29.65M $26.98M $27.11M $23.68M $21.92M
Investments and Advances $30.65M $30.50M $31.25M $19.44M $18.47M
-Available for Sale Securities $30.65M $30.50M $31.25M $19.44M $18.47M
Goodwill and Other Intangible Assets $212.24M $212.52M $212.84M $219.75M $220.45M
-Goodwill $208.59M $208.59M $208.59M $212.30M $212.30M
-Other Intangible Assets $3.65M $3.93M $4.26M $7.45M $8.15M
Non-Current Deferred Assets $42.23M – – – –
Other Non-Current Assets $3.29M $3.05M $3.05M $7.58M $5.69M
Net PPE $23.88M $21.62M $22.18M $18.73M $17.20M
Total Non-Current Assets $312.30M $267.68M $269.32M $265.52M $261.81M
Other Current Assets $6.54M $6.34M $9.53M $8.95M $5.92M
Total Assets $447.49M $400.91M $405.88M $392.08M $387.24M
Total Current Assets $135.20M $133.22M $136.56M $126.57M $125.43M
Cash and Cash Equivalents & Short-Term Investments $82.42M $81.00M $88.93M $78.95M $81.77M
-Cash and Cash Equivalents $24.00M $22.82M $33.04M $29.48M $31.90M
-Short Term Investments $58.42M $58.17M $55.89M $49.47M $49.86M
Receivables $10.65M $13.06M $7.95M $10.84M $10.06M
-Accounts Receivable $10.65M $13.06M $7.95M $10.84M $10.06M
Inventory $35.59M $32.83M $30.16M $27.83M $27.69M
Total Liabilities $27.49M $28.68M $34.00M $38.34M $40.09M
Total Current Liabilities $13.95M $18.25M $22.98M $27.15M $28.31M
Other Non-Current Liabilities $399,000.00 $183,000.00 $171,000.00 – –
Total Equity $420.00M $372.23M $371.89M $353.74M $347.16M
Stockholders' Equity $420.00M $372.23M $371.89M $353.74M $347.16M
Capital Stock $49,000.00 $49,000.00 $48,000.00 $48,000.00 $48,000.00
-Common Stock $49,000.00 $49,000.00 $48,000.00 $48,000.00 $48,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $713.57M $710.81M $711.40M $704.33M $698.42M
Retained Earnings -$293.41M -$338.51M -$339.70M -$350.77M -$351.39M
-Accumulated Depreciation -$5.77M -$5.36M -$4.93M -$4.95M -$4.72M
Non-Current Deferred Liabilities $0.00 $198,000.00 $189,000.00 $189,000.00 $175,000.00
-Long Term Capital Lease Obligation $13.15M $10.04M $10.66M $11.01M $11.60M
Long Term Debt and Capital Lease Obligation $13.15M $10.04M $10.66M $11.01M $11.60M
Payables $4.60M $5.95M $3.77M $6.57M $6.78M
-Accounts Payable $2.48M $3.75M $1.49M $2.89M $3.21M
-Total Tax Payable $2.12M $2.20M $2.28M $3.68M $3.58M
Current Accrued Expenses $2.70M $3.26M $5.85M $5.91M $4.96M
Short-Term Debt and Capital Lease Obligation $2.59M $4.82M $7.24M $9.67M $12.22M
-Current Capital Lease Obligation $2.59M $2.32M $2.24M $2.18M $2.17M
Current Deferred Liabilities $188,000.00 $206,000.00 $195,000.00 $154,000.00 $162,000.00
Total Non-Current Liabilities $13.54M $10.42M $11.02M $11.20M $11.77M
-Current Debt – $2.50M $5.00M $7.49M $10.05M
-Long Term Equity Investment – – $0.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on BLFS.

Leave a comment

Scroll to Top